blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2266595

EP2266595 - Treatment of infections and other disorders [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.01.2013
Database last updated on 07.10.2024
Most recent event   Tooltip25.01.2013Application deemed to be withdrawnpublished on 27.02.2013  [2013/09]
Applicant(s)For all designated states
Regenerx Biopharmaceuticals, Inc.
3 Bethesda Metro Center, Suite 700
Bethesda, MD 20814 / US
[2010/52]
Inventor(s)01 / Goldstein, Allan L.
800 25th Street N.W. Apt. 1005
Washington, DC 20037 / US
02 / Finkelstein, Jack JR.
3910 East-West Highway
Chevy Chase, MD 20815 / US
 [2011/26]
Former [2010/52]01 / Goldstein, Allan L.
800 25th Street N.W. Apt. 1005
Washington, DC 20037 / US
02 / Finkelstein, Jack JR.
3703 Taylor Street
Chevy Chase, MD 20815 / US
Representative(s)Klunker . Schmitt-Nilson . Hirsch
Patentanwälte
Destouchesstraße 68
80796 München / DE
[N/P]
Former [2010/52]Klunker . Schmitt-Nilson . Hirsch
Patentanwälte Destouchesstrasse 68
80796 München / DE
Application number, filing date10185311.706.02.2003
[2010/52]
Priority number, dateUS20020354250P06.02.2002         Original published format: US 354250 P
US20020421038P25.10.2002         Original published format: US 421038 P
[2010/52]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2266595
Date:29.12.2010
Language:EN
[2010/52]
Type: A3 Search report 
No.:EP2266595
Date:06.07.2011
[2011/27]
Search report(s)(Supplementary) European search report - dispatched on:EP07.06.2011
ClassificationIPC:C07K14/00, A61P31/04, A61P1/00
[2011/27]
CPC:
A61K38/08 (EP,US); A61K38/2292 (EP,US); A61P1/00 (EP);
A61P1/02 (EP); A61P1/04 (EP); A61P31/00 (EP);
A61P31/04 (EP); Y02A50/30 (EP,US) (-)
Former IPC [2010/52]A61K38/22, A61P1/00, A61P31/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2010/52]
TitleGerman:Behandlung von Infektionen und anderen Erkrankungen[2010/52]
English:Treatment of infections and other disorders[2010/52]
French:Traitement d'infections et d'autres troubles[2010/52]
Examination procedure05.01.2012Amendment by applicant (claims and/or description)
05.01.2012Examination requested  [2012/08]
01.09.2012Application deemed to be withdrawn, date of legal effect  [2013/09]
10.10.2012Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2013/09]
Parent application(s)   TooltipEP03808930.6  / EP1497322
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030808930) is  24.01.2007
Fees paidRenewal fee
03.12.2010Renewal fee patent year 03
03.12.2010Renewal fee patent year 04
03.12.2010Renewal fee patent year 05
03.12.2010Renewal fee patent year 06
03.12.2010Renewal fee patent year 07
03.12.2010Renewal fee patent year 08
15.02.2011Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
29.02.201210   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9418988  (VON ARNIM ULRICH CHRISTOPH [DE]) [X] 1-20 * whole document esp. pages 1,27 and claims 2,6,7 *;
 [X]WO9949883  (UNIV GLASGOW [GB], et al) [X] 1-20 * whole document esp. page 6 and claim 12 *;
 [A]  - YAMAMOTO T ET AL, "Thymosin beta-4 Expression Is Correlated with Metastatic Capacity of Colorectal Carcinomas", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 193, no. 2, doi:10.1006/BBRC.1993.1682, ISSN 0006-291X, (19930615), pages 706 - 710, (19930615), XP024767553 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1006/bbrc.1993.1682
by applicantWO9949883
 WO1999GB00833
 WO1999US17282
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.